Chris Lau

Chris Lau

InvestorPlace Contributor

Expertise: Technology, Biotech

Expertise:

Technology
Biotech

Education:

Bachelor of Science
Project Management Professional

Awards and Accomplishments:

Top 100 Tipranks 2015-2021

About Chris:

Chris has over two decades of investing experience. He is an Honors B.Sc graduate (with distinction) in Science and Economics. He holds a Project Management Professional designation

Chris focuses on the technology, cyclical, and healthcare sector. He runs a newsletter with speculative Triple-baggers.

His investment strategy is based on finding undervalued stocks trading at a steep discount to their intrinsic value.

Follow Chris on DIY Value Investing.

Recent Articles

Why It’s Worth Betting Against Tilray Stock

By Chris Lau, InvestorPlace Contributor

TLRY stock will lose more money for investors as Tilray's losses mount and the stock gets diluted in the longer term.

Why Fubo Stock Should Be Bought on Weakness Now

By Chris Lau, InvestorPlace Contributor

The acceleration of fuboTV’s user growth will increase the growth of its advertising and sports betting revenue, lifting FUBO stock in the process.

Intel Stock Is Gearing Up for a Serious Breakout Here

By Chris Lau, InvestorPlace Contributor

Intel will launch a discrete graphics card release that will lead to expanding margins, as it takes on Nvidia and AMD.

Start Accumulating SoFi Stock Before Its Inevitable Move Back Up

By Chris Lau, InvestorPlace Contributor

When SoFi (NASDAQ:SOFI) posted an unexpected loss from student loan refinancing, the company lost some bullish momentum. Since the disclosure in August, SoFi stock is…

7 Blue Chips to Shield Your Portfolio From Market Downturn

By Chris Lau, InvestorPlace Contributor

Blue-chip stocks that have growing cash flow, good value, and have strong growth are suitable investments as the market downturn worsens.

Load More